論文

査読有り 国際誌
2021年4月

Role of the IL-23-T-bet/GATA3 Axis for the Pathogenesis of Ulcerative Colitis

Inflammation
  • Haruei Ogino
  • Keita Fukaura
  • Yoichiro Iboshi
  • Yousuke Nagamatsu
  • Hiroaki Okuno
  • Kei Nishioka
  • Yuichiro Nishihara
  • Yoshimasa Tanaka
  • Takatoshi Chinen
  • Eikich Ihara
  • Yoshihiro Ogawa
  • 全て表示

44
2
開始ページ
592
終了ページ
603
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s10753-020-01358-y
出版者・発行元
Springer Science and Business Media LLC

Ulcerative colitis (UC) has been considered a Th2- and Th17-related disease. However, anti-IL-12/23 p40 antibody, which blocks Th1 and Th17 cell induction and maintenance, has shown efficacy in treating UC, suggesting that UC might not be a prototypical Th2 and Th17 cell-mediated autoimmune disease. To verify how the immune responses in UC patients interact with each other, we analyzed the cytokine expression and transcription factors involved in the Th1, Th2, and Th17 responses. The mucosal expression of 19 cytokines and transcription factors related to Th1, Th2, and Th17 cells, as well as Tregs, were measured by quantitative polymerase chain reaction using endoscopic biopsy specimens from inflamed colons of UC patients. A correlation analysis between the cytokines and transcription factors was conducted. The characteristic cytokine profile in UC patients has two immune response clusters: Th17-related responses and Th1-/Th2-related responses. IL-23 showed a weaker association with Th17 cell-related cytokines and transcription factor RORC and a much stronger correlation with T-bet and GATA3. In the high-IL-23-expression group, the rate of chronic continuous type was higher and the remission rate lower than in the low-IL-23-expression group. IL-23 may be a very important cytokine for evaluating the UC disease condition, as the expression of IL-23 is associated with certain clinical characteristics of UC patients. A unique association between IL-23 and T-bet/GATA3 might play a key role in the pathogenesis of UC.

リンク情報
DOI
https://doi.org/10.1007/s10753-020-01358-y
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33040251
URL
http://link.springer.com/content/pdf/10.1007/s10753-020-01358-y.pdf
URL
http://link.springer.com/article/10.1007/s10753-020-01358-y/fulltext.html
ID情報
  • DOI : 10.1007/s10753-020-01358-y
  • ISSN : 0360-3997
  • eISSN : 1573-2576
  • PubMed ID : 33040251

エクスポート
BibTeX RIS